• Fri, February 5, 2021

by: WOPRAI

Craig Irwin Initiated (BLNK) at Strong Buy and Held Target at $67 on, Feb 5th, 2021

by: WOPRAI

Brandon Couillard Maintained (BIO) at Strong Buy with Increased Target to $725 on, Feb 5th, 2021

by: WOPRAI

Josh Beck Maintained (BILL) at Buy with Increased Target to $165 on, Feb 5th, 2021

by: WOPRAI

Scott Berg Maintained (BILL) at Strong Buy with Increased Target to $170 on, Feb 5th, 2021

by: WOPRAI

Brian Schwartz Maintained (BILL) at Buy with Increased Target to $175 on, Feb 5th, 2021

by: WOPRAI

John Hodulik Maintained (TMUS) at Strong Buy and Held Target at $150 on, Feb 5th, 2021

by: WOPRAI

George Choi Upgraded (WYNN) to Hold and Increased Target to $110 on, Feb 5th, 2021

by: WOPRAI

John Walsh Maintained (XYL) at Sell with Increased Target to $90 on, Feb 5th, 2021

by: WOPRAI

Andrew Kaplowitz Maintained (XYL) at Hold with Decreased Target to $109 on, Feb 5th, 2021

by: WOPRAI

Lauren Silberman Maintained (YUM) at Hold with Increased Target to $108 on, Feb 5th, 2021

by: WOPRAI

Brian Mullan Maintained (YUM) at Strong Buy with Increased Target to $113 on, Feb 5th, 2021

by: WOPRAI

Lawrence Keusch Maintained (BAX) at Buy with Decreased Target to $85 on, Feb 5th, 2021

by: WOPRAI

Matt Miksic Maintained (BAX) at Buy with Decreased Target to $95 on, Feb 5th, 2021

by: WOPRAI

Tycho Peterson Downgraded (TWST) to Sell and Held Target at $100 on, Feb 5th, 2021

by: WOPRAI

Catherine Schulte Maintained (TWST) at Buy with Increased Target to $200 on, Feb 5th, 2021

by: WOPRAI

Chris Kapsch Maintained (AVY) at Strong Buy with Increased Target to $187 on, Feb 5th, 2021

by: WOPRAI

Courtney Yakavonis Maintained (AGCO) at Buy with Increased Target to $145 on, Feb 5th, 2021

by: WOPRAI

Jamie Cook Maintained (AGCO) at Hold with Increased Target to $131 on, Feb 5th, 2021

by: WOPRAI

Chris Brendler Initiated (AFRM) at Hold on, Feb 5th, 2021

by: WOPRAI

Jake Fuller Downgraded (ANGI) to Hold on, Feb 5th, 2021

by: WOPRAI

PJ Juvekar Downgraded (APD) to Hold and Decreased Target to $277 on, Feb 5th, 2021

by: WOPRAI

Chris Parkinson Maintained (APD) at Buy with Decreased Target to $302 on, Feb 5th, 2021

by: WOPRAI

David Begleiter Maintained (APD) at Strong Buy with Decreased Target to $300 on, Feb 5th, 2021

by: WOPRAI

Matthew DeGulis Maintained (TPR) at Buy with Increased Target to $41 on, Feb 5th, 2021

by: WOPRAI

Rick Patel Maintained (TPR) at Strong Buy with Increased Target to $41 on, Feb 5th, 2021

by: WOPRAI

Michael Binetti Maintained (TPR) at Hold with Increased Target to $39 on, Feb 5th, 2021

by: WOPRAI

Adrienne Yih Maintained (TPR) at Buy with Increased Target to $44 on, Feb 5th, 2021

by: WOPRAI

Ike Boruchow Maintained (TPR) at Buy with Increased Target to $45 on, Feb 5th, 2021

by: WOPRAI

Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $90 on, Feb 5th, 2021

by: WOPRAI

Jonathan Atkin Maintained (TMUS) at Hold with Increased Target to $133 on, Feb 5th, 2021

by: WOPRAI

Greg Miller Maintained (TMUS) at Strong Buy with Increased Target to $150 on, Feb 5th, 2021

by: WOPRAI

Craig Siegenthaler Maintained (BSIG) at Buy with Decreased Target to $27 on, Feb 5th, 2021

by: WOPRAI

Mark Dwelle Maintained (AFL) at Hold with Increased Target to $47 on, Feb 5th, 2021

by: WOPRAI

Richard Valera Upgraded (ADTN) to Strong Buy and Held Target at $20 on, Feb 5th, 2021

by: WOPRAI

Heath Terry Upgraded (ZG) to Strong Buy and Increased Target to $200 on, Feb 5th, 2021

by: WOPRAI

Heath Terry Upgraded (Z) to Strong Buy and Increased Target to $200 on, Feb 5th, 2021

by: WOPRAI

Mike Matson Maintained (ZBH) at Strong Buy with Increased Target to $192 on, Feb 5th, 2021

by: WOPRAI

Matthew Bouley Maintained (WMS) at Buy with Increased Target to $115 on, Feb 5th, 2021

by: WOPRAI

Garik Shmois Maintained (WMS) at Strong Buy with Increased Target to $120 on, Feb 5th, 2021

by: WOPRAI

Wamsi Mohan Upgraded (TDC) to Strong Buy and Held Target at $55 on, Feb 5th, 2021

by: WOPRAI

Katy Huberty Maintained (TDC) at Hold with Increased Target to $30 on, Feb 5th, 2021

by: WOPRAI

Zhen Yang Maintained (ARW) at Hold with Increased Target to $110 on, Feb 5th, 2021

by: WOPRAI

Keay Nakae Maintained (ARWR) at Strong Buy with Increased Target to $97 on, Feb 5th, 2021

by: WOPRAI

Patrick Trucchio Maintained (ARWR) at Strong Buy with Increased Target to $95 on, Feb 5th, 2021

by: WOPRAI

Edward Tenthoff Maintained (ARWR) at Buy with Increased Target to $99 on, Feb 5th, 2021

by: WOPRAI

Bobby Griffin Initiated (ARKO) at Strong Buy and Held Target at $13 on, Feb 5th, 2021

by: WOPRAI

Chris Parkinson Maintained (ASH) at Buy with Increased Target to $103 on, Feb 5th, 2021

by: WOPRAI

Joshua Pokrzywinski Maintained (AME) at Buy with Increased Target to $133 on, Feb 5th, 2021

Jason McCarthy Upgraded (BCLI) to Strong Buy on, Feb 5th, 2021

Jason McCarthy of Maxim Group, Upgraded "Brainstorm Cell Therapeutics Inc." (BCLI) to Strong Buy on, Feb 5th, 2021.

Jason, nor any peers, have made any analyst calls on BCLI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30